AGWCA
ONC icon

Annis Gardner Whiting Capital Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-36
Closed -$5.14K – 964
2024
Q2 		$5.14K Hold
36
– – ﹤0.01% 772
2024
Q1 		$5.63K Buy
+36
New +$5.8K ﹤0.01% 748

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's ONC Position: Q3 2024 in Review

Annis Gardner Whiting Capital Advisors sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 36 shares — an estimated $5.14K sold.

Annis Gardner Whiting Capital Advisors first reported a position in ONC in Q1 2024 and held it in 2 quarters. The position peaked at $5.63K in Q1 2024. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Annis Gardner Whiting Capital Advisors reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 36 BeOne Medicines Ltd shares in Q3 2024, an estimated $5.14K.
  • Annis Gardner Whiting Capital Advisors first reported a position in BeOne Medicines Ltd in Q1 2024 and held it in 2 quarters.
  • Annis Gardner Whiting Capital Advisors's BeOne Medicines Ltd position peaked at $5.63K in Q1 2024.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.